Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA has cautioned consumers about ‘Generic Tamiflu,’ a potentially harmful product sold over the Internet. FDA tests revealed that the fraudulent product does not contain the active ingredient of Tamiflu, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin.
Subscribe to our email newsletter
FDA warned the consumers who had already faced adverse reactions from penicillin products and said that they are at risk of experiencing similar reactions from cloxacillin.
This includes a anaphylaxis, with symptoms that include difficulty breathing, chest tightness, swelling of the throat or tongue, hives, dizziness, loss of consciousness, or a rapid or weak pulse. To date, the FDA is not aware of any reports of adverse reactions.
According to the FDA there is no FDA-approved generic drug for the prescription product Tamiflu.
The FDA said that its purchased product arrived in an envelope postmarked from India, containing two foil-backed blister packages each with 15 yellow and tan capsules containing white powder. The foil backing is printed, and labeled in part, ‘Oseltamivir Phosphate 75mg capsules TM-FLU capsules’ and ‘Manufactured by: Trydrugs Pharmaceuticals.’
Margaret Hamburg, commissioner of FDA, said: “A rogue Internet website marketing drug products may look like a professional and legitimate website, but may actually be an illegal operation.
“Medicines purchased from websites operating outside the law put consumers at increased risk due to a higher risk that the products will be counterfeit, impure, contaminated, or have too little or too much of the active ingredient.”